All In Biotech

Drug Trial Radar · NCT02447536

Trial of Two Strains of BCG

Evaluating the Effect of Different BCG Strains on Early Life Hospital Admissions in Guinea-Bissau: A Randomised Trial

Last checked: Nov 19, 2026Latest source record: Dec 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 12,006 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

12,006

Actual

Start

Dec 8, 2014

Primary completion

Nov 24, 2017

Study completion May 1, 2018

Sponsor

Lead sponsor
Bandim Health ProjectAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Statens Serum Institut
First posted
May 19, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The investigators aim to conduct a randomised controlled trial comparing two Bacille Calmette-Guérin (BCG) strains currently used in Guinea-Bissau, the Danish and the Russian, in terms of prevention of neonatal and early life morbidity and mortality, immune responses and adverse events related to BCG vaccination. The primary outcome will be hospital admissions within 6 weeks of age.

Conditions

  • Morbidity
  • Bacille Calmette-Guérin

Interventions

  • BCG-Denmark 1331 (Statens Serum Institute)Biological

    See above

  • BCG-Russia-I (Serum Institute of India)Biological

    See above

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hospital admissionTime frame: 6 weeks after birth

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bandim Health Project, Apartado 861

    Bissau, Guinea-Bissau

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.